Skip to main content

Peer Review reports

From: CXCL10 is a prognostic marker for pancreatic adenocarcinoma and tumor microenvironment remodeling

Original Submission
10 Mar 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
8 Apr 2022 Reviewed Reviewer Report
10 Apr 2022 Reviewed Reviewer Report
20 Dec 2022 Author responded Author comments - Xuan Zhu
Resubmission - Version 4
20 Dec 2022 Submitted Manuscript version 4
8 Jan 2023 Author responded Author comments - Xuan Zhu
Resubmission - Version 5
8 Jan 2023 Submitted Manuscript version 5
9 Jan 2023 Author responded Author comments - Xuan Zhu
Resubmission - Version 6
9 Jan 2023 Submitted Manuscript version 6
13 Jan 2023 Reviewed Reviewer Report
29 Jan 2023 Author responded Author comments - Xuan Zhu
Resubmission - Version 7
29 Jan 2023 Submitted Manuscript version 7
1 Feb 2023 Author responded Author comments - Xuan Zhu
Resubmission - Version 8
1 Feb 2023 Submitted Manuscript version 8
2 Feb 2023 Author responded Author comments - Xuan Zhu
Resubmission - Version 9
2 Feb 2023 Submitted Manuscript version 9
Publishing
6 Feb 2023 Editorially accepted
13 Feb 2023 Article published 10.1186/s12885-023-10615-w

You can find further information about peer review here.

Back to article page